{"ticker": {"uuid": "791d8830-adf1-443b-98a7-e98580489d5d", "symbol": "APM", "name": "Aptorum Group Ltd Class A", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Aptorum Group Limited (APM) Edges Lower Amid Narrow Trading Range - Rating Change", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQSzljRjRqVDJYV19GXzZpeTMyd3ltbG5VVG5lOWgxTXc5NGhUamJLY3JSWFpUV0FZZGhOczdsS0s3dHZmOU1QU2FtemktLWpPOHA1aG9yeExNSlFKYy1LTEVKVVEtWUExNFBYMmlnTlRtSmkwZmhlZ0JrMVBSZVpTUVdqUDJIanc3ejRLcjNPMmY2NzRkS0RoazFYWE1IUHFaX2thS0hNdkNQZGlOblQtbw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-07-11T15:40:15+00:00", "published_display": "11 Jul 2026 15:40", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer\u2019s Association International Conference", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/aptorum-group-diamir-biosciences-announce-120000793.html", "source_name": "GlobeNewswire", "published_at": "2026-07-08T12:00:00+00:00", "published_display": "08 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 6K Aptorum Group Ltd For: 22 June By Investing.com", "summary": "This article reports on the filing of Form 6K by Aptorum Group Ltd for June 22. It mentions the company's stock symbol APM and its trading performance, noting a -3.50% change. The content primarily serves as a notice of the regulatory filing and includes various market data and n", "url": "https://za.investing.com/news/stock-market-news/form-6k-aptorum-group-ltd-for-22-june-93CH-4338762", "source_name": "Investing.com South Africa", "published_at": "2026-06-23T05:39:46", "published_display": "23 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum's Merger Target DiamiR Begins Alzheimer's Biomarker Study With AlzLabs", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/aptorum-apos-merger-target-diamir-142100126.html", "source_name": "MT Newswires", "published_at": "2026-06-22T14:21:00+00:00", "published_display": "22 Jun 2026 14:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer\u2019s Disease Biomarkers", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/aptorum-group-announces-collaboration-between-120000904.html", "source_name": "GlobeNewswire", "published_at": "2026-06-22T12:00:00+00:00", "published_display": "22 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Shareholders Approve Proposed Merger With DiamiR Biosciences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/aptorum-shareholders-approve-proposed-merger-123617881.html", "source_name": "MT Newswires", "published_at": "2026-06-10T12:36:17+00:00", "published_display": "10 Jun 2026 12:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/aptorum-group-announces-shareholder-approval-120000659.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T12:00:00+00:00", "published_display": "10 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Slumps 8.79% \u2013 Key Support Test Looms for APM Stock - Fair Value Gap", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPckZOSkItdVpaZUlzbERHVThyZEpSSzZIRmtuRzNUTnR3NHVSeF9hblM4WHRPWlhhUGdkN3NRUk56SGxiMFZOb09CWDNxR2FJNlAwY0wzeFBOY3BFbllnXzVzT3Y3Rjk0Z3ZONWZoVjJEdFNvVmZPanA5cVZOenFPbW5WbVZqMGFhMnJrdUprSVotMHh0VHBsTnh0ZEs5dTdKVzEyekxpLUU3V0hNV2t3?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Slumps 8.79% \u2013 Key Support Test Looms for APM Stock - Earnings Miss Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNRVppM1lSV0g3OTRhX0dSa3FmX2ViSE9PTmo0YWFFQ2llaEdyM09sa28wclpoZ3FwZXVpTkQxQjVPVFVtSjFxT0ZiYjd3amVYSlRZcHY0UnpGdHRTV1lYR1pQb0gyY1FIUktLUEZZSzRuX3NtYW1UQ2dtRWxIejNwODBxazlKRHBvdjI2SUVjZjFudEI4cUtWa1RJeUI0Z2tOMEhWcFdNRGg?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "APM - Aptorum Group Ltd Stock Price and Quote", "summary": "This article provides comprehensive financial data, news, and performance metrics for Aptorum Group Ltd (APM). It includes details on stock price, market capitalization, key financial ratios, insider ownership, and a history of corporate announcements and news related to the comp", "url": "https://finviz.com/stock?t=APM", "source_name": "Finviz", "published_at": "2026-06-01T08:40:31", "published_display": "01 Jun 2026 08:40", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "APM | Aptorum Group Limited Class Insider Trading", "summary": "This article provides an overview of Aptorum Group Limited Class A Ordinary Shares (APM) with a focus on insider trading activity, institutional holdings, and other financial data. It indicates that there has been no recent insider trading for this ticker and very limited data fo", "url": "https://www.quiverquant.com/stock/APM/insiders/", "source_name": "Quiver Quantitative", "published_at": "2026-05-23T18:10:17", "published_display": "23 May 2026 18:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look At Andean Precious Metals (TSX:APM) Valuation After Record Q1 Results And Planned NYSE Listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNeUNDcFhhWXlkamEzZXNlRm9GM2tYV3dIN3N0alllazdIMWI3M1FTRmdnZGl5V09CWDNOekpKUF9ST0JFVTlGZTh3czRtYzExWUJFdHVpV054TjBWSjJaQjlJa1ByT2VpWVAzRUx4cUhGcXQ2dmxqaVFyTHF0TTRWaURmUQ?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "If You Invested $1,000 in Aptorum Group Ltd (APM)", "summary": "This article analyzes the historical performance of a $1,000 investment in Aptorum Group Ltd (APM) over various periods, showing significant losses over 5 and 10 years, but a gain in the last year. It also provides a detailed overview of Aptorum Group, a clinical-stage biopharmac", "url": "https://www.stocktitan.net/tools/stock-return-calculator/APM", "source_name": "Stock Titan", "published_at": "2026-03-23T03:40:13", "published_display": "23 Mar 2026 03:40", "sentiment": "negative", "sentiment_pct": 19, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] Aptorum Group Ltd Current Report (Foreign Issuer) | APM SEC Filing - Form 6-K", "summary": "Aptorum Group Limited filed a Form 6-K reporting the results of its 2025 annual meeting of shareholders held on March 10, 2026. The report details the voting outcomes for the re-election of Class I directors, Justin Wu and Douglas Arner, and the re-appointment of Marcum Asia CPAs", "url": "https://www.stocktitan.net/sec-filings/APM/6-k-aptorum-group-ltd-current-report-foreign-issuer-9f1e0ebee461.html", "source_name": "Stock Titan", "published_at": "2026-03-16T06:09:02", "published_display": "16 Mar 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Blood test study takes aim at glioblastoma, deadliest brain cancer", "summary": "Aptorum Group and DiamiR Biosciences announced the publication of a study in \"Diagnostics\" demonstrating the feasibility of using microRNA-based blood tests to detect glioblastoma, the most aggressive and lethal form of brain cancer. This study, conducted with the University of P", "url": "https://www.stocktitan.net/news/APM/aptorum-group-and-diami-r-biosciences-announce-publication-of-micro-k3gy5kwhzw73.html", "source_name": "Stock Titan", "published_at": "2026-03-10T15:39:41", "published_display": "10 Mar 2026 15:39", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania", "summary": "Aptorum Group and DiamiR Biosciences have announced the publication of a study in Diagnostics detailing the development of microRNA-based glioblastoma biomarkers. This research, conducted with the University of Pennsylvania, outlines a minimally invasive blood plasma test for det", "url": "https://www.chartmill.com/news/APM/gnwcq-2026-3-10-aptorum-group-and-diamir-biosciences-announce-publication-of-microrna-glioblastoma-biomarker-study-in-diagnostics-in-collaboration-with-the-university-of-pennsylvania", "source_name": "ChartMill", "published_at": "2026-03-09T09:40:10", "published_display": "09 Mar 2026 09:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Aptorum faces Nasdaq $1 warning but keeps listing for now", "summary": "Aptorum Group (NASDAQ: APM) received a Nasdaq notification for non-compliance with the $1 minimum bid price rule. The company has a 180-calendar-day grace period until September 1, 2026, to regain compliance and is exploring options, including a potential reverse stock split. The", "url": "https://www.stocktitan.net/news/APM/aptorum-group-limited-announces-receipt-of-nasdaq-notification-a0kht9lxwp6f.html", "source_name": "Stock Titan", "published_at": "2026-03-07T14:34:44", "published_display": "07 Mar 2026 14:34", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "APM - Aptorum Group Ltd Latest Stock News & Market Updates", "summary": "This article provides an overview of Aptorum Group Ltd (APM) stock, highlighting its focus on developing therapeutic assets for oncology and infectious diseases, and its proposed merger with DiamiR Biosciences Corp. It also details recent corporate news, including clinical trial ", "url": "https://www.stocktitan.net/news/APM/page-8.html", "source_name": "Stock Titan", "published_at": "2026-02-26T16:51:36", "published_display": "26 Feb 2026 16:51", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Automated Alzheimer\u2019s risk gene test to be vetted in DiamiR lab", "summary": "Aptorum Group announced a collaboration between its subsidiary DiamiR Biosciences and Instant NanoBiosensors (INB) to validate INB's automated APOE testing platform for Alzheimer\u2019s disease risk assessment. This validation will occur in DiamiR's CLIA-certified and CAP-accredited l", "url": "https://www.stocktitan.net/news/APM/aptorum-group-announces-a-collaboration-between-diami-r-biosciences-r3knj3olkw1k.html", "source_name": "Stock Titan", "published_at": "2026-02-02T12:57:49", "published_display": "02 Feb 2026 12:57", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB\u2019s Automated APOE Testing Platform for Alzheimer\u2019s Disease", "summary": "Aptorum Group announced a collaboration between DiamiR Biosciences and Instant NanoBiosensors (INB) to validate INB's automated APOE testing platform for Alzheimer's disease. DiamiR will compare INB's G8 Genotyping Analyzer with its New York State approved APOE test to assess its", "url": "https://finance.yahoo.com/news/aptorum-group-announces-collaboration-between-130000993.html", "source_name": "Market source", "published_at": "2026-02-02T01:09:49", "published_display": "02 Feb 2026 01:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group, DiamiR announce New York state approval for APOE Genotyping test", "summary": "DiamiR Biosciences and Aptorum Group announced that DiamiR received a Clinical Laboratory Evaluation Program (CLEP) Test Approval for its APOE Genotyping test from the New York State Department of Health (NYSDOH). This approval allows DiamiR to offer its validated APOE Genotyping", "url": "https://www.tipranks.com/news/the-fly/aptorum-group-diamir-announce-new-york-state-approval-for-apoe-genotyping-test-thefly", "source_name": "TipRanks", "published_at": "2025-11-02T11:40:18", "published_display": "02 Nov 2025 11:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "This article provides a detailed stock quote and forecast for Aptorum Group Limited Class A (APM). It covers current and after-hours trading prices, key stock statistics, company information, financial data, and analyst ratings, including a 1-year stock price forecast. The report", "url": "https://www.cnn.com/markets/stocks/APM", "source_name": "CNN", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Up to $6M: Aptorum Group to Sell 1,000,000 Shares in Registered Direct Offering", "summary": "Aptorum Group (NASDAQ: APM) announced a registered direct offering of 1,000,000 Class A ordinary shares at $2.00 per share, aiming to raise $2.0 million. Concurrently, the company will issue unregistered warrants to purchase up to 2,000,000 additional shares at the same price, po", "url": "https://www.stocktitan.net/news/APM/aptorum-group-limited-announces-up-to-6-million-registered-direct-woxzu0wauuyn.html", "source_name": "Stock Titan", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group stock falls after $2 million direct offering By Investing.com", "summary": "Aptorum Group Limited's stock tumbled 23% following the announcement of a $2 million registered direct offering and concurrent private placement. The biopharmaceutical company will sell 1,000,000 Class A ordinary shares at $2.00 per share and issue warrants to purchase up to 2,00", "url": "https://au.investing.com/news/stock-market-news/aptorum-group-stock-falls-after-2-million-direct-offering-93CH-4055939", "source_name": "Investing.com Australia", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "YOOV Group Holding Limited cancelled the acquisition of Aptorum Group Limited from Jurchen Investment Corporation and others in a reverse merger transaction.", "summary": "YOOV Group Holding Limited has cancelled its acquisition of Aptorum Group Limited in a reverse merger transaction that was initially announced on March 1, 2024. The deal, valued at $250 million, would have resulted in YOOV shareholders owning approximately 90% of the combined com", "url": "https://www.marketscreener.com/quote/stock/APTORUM-GROUP-LIMITED-49518117/news/YOOV-Group-Holding-Limited-cancelled-the-acquisition-of-Aptorum-Group-Limited-from-Jurchen-Investmen-48178350/", "source_name": "MarketScreener", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Announces Completion of $3 Million Convertible Note due 2023", "summary": "Aptorum Group Limited announced the completion of a private offering of a $3 million convertible note due in December 2023. The note was solely subscribed by Aenco Technologies Limited, an entity indirectly owned by Aptorum's Non-Executive Director and major shareholder, Mr. Ian ", "url": "https://www.businesswire.com/news/home/20221216005085/en/Aptorum-Group-Announces-Completion-of-%243-Million-Convertible-Note-due-2023", "source_name": "Business Wire", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group To Acquire U Group", "summary": "Aptorum Group Limited announced its intention to acquire URF Holding Group Limited, a company focused on urban revitalization in China, through a non-binding Letter of Intent and Term Sheet. The acquisition, which involves a reverse takeover, will result in Aptorum distributing i", "url": "https://www.citybiz.co/article/396543/aptorum-group-to-acquire-u-group/", "source_name": "citybiz", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement | APM Stock News", "summary": "Aptorum Group (APM) has regained compliance with Nasdaq's minimum bid price requirement by maintaining a closing bid price of at least $1.00 for ten consecutive business days between July 16 and July 30, 2025. This resolution addresses an earlier notice from Nasdaq dated April 15", "url": "https://www.quiverquant.com/news/Aptorum+Group+Regains+Compliance+with+Nasdaq's+Minimum+Bid+Price+Requirement", "source_name": "Quiver Quantitative", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group raises $2 million in registered direct offering", "summary": "Aptorum Group Limited has successfully raised $2 million through a registered direct offering of 1 million Class A ordinary shares priced at $2.00 per share, with a concurrent private placement potentially generating an additional $4 million from warrants. The biopharmaceutical c", "url": "https://in.investing.com/news/company-news/aptorum-group-raises-2-million-in-registered-direct-offering-93CH-5039528", "source_name": "Investing.com India", "published_at": "2025-10-10T19:32:00", "published_display": "10 Oct 2025 19:32", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering", "summary": "Aptorum Group Limited has announced a registered direct offering of 1,000,000 Class A ordinary shares at $2.00 per share, aiming to raise $2 million upfront. The offering also includes unregistered warrants to purchase up to an additional 2,000,000 shares, potentially generating ", "url": "https://markets.financialcontent.com/startribune/article/gnwcq-2025-10-10-aptorum-group-limited-announces-up-to-6-million-registered-direct-offering", "source_name": "FinancialContent", "published_at": "2025-10-10T09:54:00", "published_display": "10 Oct 2025 09:54", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "APM | Aptorum Group Limited Class Institutional Ownership", "summary": "This article provides an overview of Aptorum Group Limited (APM) Class A Ordinary Shares, focusing on institutional ownership, insider trading, and various financial metrics. It includes data sections for Congress trading, whale activity, corporate lobbying, revenue breakdown, an", "url": "https://www.quiverquant.com/stock/APM/institutions/", "source_name": "Quiver Quantitative", "published_at": "2025-09-01T12:51:25", "published_display": "01 Sep 2025 12:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group\u2019s Latest Surge: An Opportunity?", "summary": "Aptorum Group Limited (APM) saw a significant stock surge of 134.65% following positive trial results, FDA designation announcements, and an impending all-stock merger with DiamiR Biosciences. The company also maintained NASDAQ compliance, positioning itself for potential growth ", "url": "https://stockstotrade.com/news/aptorum-group-limited-apm-news-2025_08_21/", "source_name": "StocksToTrade", "published_at": "2025-08-21T10:04:00", "published_display": "21 Aug 2025 10:04", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Limited Regains Compliance with NASDAQ's Minimum Bid Price Requirement", "summary": "Aptorum Group Limited has regained compliance with Nasdaq's minimum bid price requirement, fulfilling the condition of its Class A ordinary shares closing at $1.00 or higher for 10 consecutive business days. This comes after an initial notice from Nasdaq in April 2025. The compan", "url": "https://markets.financialcontent.com/worldnow.kwtv/article/gnwcq-2025-8-4-aptorum-group-limited-regains-compliance-with-nasdaqs-minimum-bid-price-requirement", "source_name": "FinancialContent", "published_at": "2025-08-04T08:15:00", "published_display": "04 Aug 2025 08:15", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "APM Stock Price, News & Analysis", "summary": "Aptorum Group Limited (NASDAQ: APM) is a clinical-stage biopharmaceutical company focused on oncology and infectious diseases, also involved in diagnostics and healthcare services. APM is currently undergoing an all-stock merger with DiamiR Biosciences Corp., which will make Diam", "url": "https://www.stocktitan.net/overview/APM/", "source_name": "Stock Titan", "published_at": "2025-04-24T19:39:14", "published_display": "24 Apr 2025 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group (APM) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE9SRzVLZEc3WTdGYVBwYjB4X1hyYkFlbFpYWHZ4MFdoWWstZFhNWXBISklfc0k3VnROLURuQmZSQjRqeFNnYmJjMklNQlVTSTNUOWc?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:29:35+00:00", "published_display": "24 Apr 2025 17:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency", "summary": "Aptorum Group Limited announced it received a Nasdaq notification for not meeting the minimum bid price requirement of $1 per share. The company has a 180-calendar-day grace period until October 14, 2025, to regain compliance and is exploring options including a reverse stock spl", "url": "https://www.dcnewsnow.com/business/press-releases/globenewswire/9423537/aptorum-group-limited-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-deficiency/", "source_name": "DC News Now", "published_at": "2025-04-16T12:27:00", "published_display": "16 Apr 2025 12:27", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering", "summary": "Aptorum Group Limited (NASDAQ: APM) announced it has entered into a securities purchase agreement with several institutional investors for a registered direct offering of 1,535,000 Class A Ordinary Shares at $2.00 per share, aiming to raise approximately $3.0 million. The offerin", "url": "https://markets.financialcontent.com/worldnow.kwtv/article/gnwcq-2025-1-2-aptorum-group-limited-announces-pricing-of-30-million-registered-direct-offering", "source_name": "FinancialContent", "published_at": "2025-01-02T10:55:00", "published_display": "02 Jan 2025 10:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Aptorum Group Limited (APM) Edges Lower Amid Narrow Trading Range - Rating Change", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQSzljRjRqVDJYV19GXzZpeTMyd3ltbG5VVG5lOWgxTXc5NGhUamJLY3JSWFpUV0FZZGhOczdsS0s3dHZmOU1QU2FtemktLWpPOHA1aG9yeExNSlFKYy1LTEVKVVEtWUExNFBYMmlnTlRtSmkwZmhlZ0JrMVBSZVpTUVdqUDJIanc3ejRLcjNPMmY2NzRkS0RoazFYWE1IUHFaX2thS0hNdkNQZGlOblQtbw?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-07-11T15:40:15+00:00", "published_display": "11 Jul 2026 15:40", "sentiment": "negative", "sentiment_pct": 34, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group and DiamiR Biosciences Announce Three Presentations at 2026 Alzheimer\u2019s Association International Conference", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/aptorum-group-diamir-biosciences-announce-120000793.html", "source_name": "GlobeNewswire", "published_at": "2026-07-08T12:00:00+00:00", "published_display": "08 Jul 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 6K Aptorum Group Ltd For: 22 June By Investing.com", "summary": "This article reports on the filing of Form 6K by Aptorum Group Ltd for June 22. It mentions the company's stock symbol APM and its trading performance, noting a -3.50% change. The content primarily serves as a notice of the regulatory filing and includes various market data and n", "url": "https://za.investing.com/news/stock-market-news/form-6k-aptorum-group-ltd-for-22-june-93CH-4338762", "source_name": "Investing.com South Africa", "published_at": "2026-06-23T05:39:46", "published_display": "23 Jun 2026 05:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum's Merger Target DiamiR Begins Alzheimer's Biomarker Study With AlzLabs", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/aptorum-apos-merger-target-diamir-142100126.html", "source_name": "MT Newswires", "published_at": "2026-06-22T14:21:00+00:00", "published_display": "22 Jun 2026 14:21", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Announces Collaboration between DiamiR Biosciences and AlzLabs Precision Diagnostics for Alzheimer\u2019s Disease Biomarkers", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/aptorum-group-announces-collaboration-between-120000904.html", "source_name": "GlobeNewswire", "published_at": "2026-06-22T12:00:00+00:00", "published_display": "22 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Shareholders Approve Proposed Merger With DiamiR Biosciences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/aptorum-shareholders-approve-proposed-merger-123617881.html", "source_name": "MT Newswires", "published_at": "2026-06-10T12:36:17+00:00", "published_display": "10 Jun 2026 12:36", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Announces Shareholder Approval of Proposed Merger with DiamiR Biosciences", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/aptorum-group-announces-shareholder-approval-120000659.html", "source_name": "GlobeNewswire", "published_at": "2026-06-10T12:00:00+00:00", "published_display": "10 Jun 2026 12:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Slumps 8.79% \u2013 Key Support Test Looms for APM Stock - Fair Value Gap", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxPckZOSkItdVpaZUlzbERHVThyZEpSSzZIRmtuRzNUTnR3NHVSeF9hblM4WHRPWlhhUGdkN3NRUk56SGxiMFZOb09CWDNxR2FJNlAwY0wzeFBOY3BFbllnXzVzT3Y3Rjk0Z3ZONWZoVjJEdFNvVmZPanA5cVZOenFPbW5WbVZqMGFhMnJrdUprSVotMHh0VHBsTnh0ZEs5dTdKVzEyekxpLUU3V0hNV2t3?oc=5", "source_name": "Donan\u0131mHaber", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Slumps 8.79% \u2013 Key Support Test Looms for APM Stock - Earnings Miss Risk", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxNRVppM1lSV0g3OTRhX0dSa3FmX2ViSE9PTmo0YWFFQ2llaEdyM09sa28wclpoZ3FwZXVpTkQxQjVPVFVtSjFxT0ZiYjd3amVYSlRZcHY0UnpGdHRTV1lYR1pQb0gyY1FIUktLUEZZSzRuX3NtYW1UQ2dtRWxIejNwODBxazlKRHBvdjI2SUVjZjFudEI4cUtWa1RJeUI0Z2tOMEhWcFdNRGg?oc=5", "source_name": "dars.gov.et", "published_at": "2026-06-02T07:00:00+00:00", "published_display": "02 Jun 2026 07:00", "sentiment": "negative", "sentiment_pct": 18, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "APM - Aptorum Group Ltd Stock Price and Quote", "summary": "This article provides comprehensive financial data, news, and performance metrics for Aptorum Group Ltd (APM). It includes details on stock price, market capitalization, key financial ratios, insider ownership, and a history of corporate announcements and news related to the comp", "url": "https://finviz.com/stock?t=APM", "source_name": "Finviz", "published_at": "2026-06-01T08:40:31", "published_display": "01 Jun 2026 08:40", "sentiment": "negative", "sentiment_pct": 35, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "APM | Aptorum Group Limited Class Insider Trading", "summary": "This article provides an overview of Aptorum Group Limited Class A Ordinary Shares (APM) with a focus on insider trading activity, institutional holdings, and other financial data. It indicates that there has been no recent insider trading for this ticker and very limited data fo", "url": "https://www.quiverquant.com/stock/APM/insiders/", "source_name": "Quiver Quantitative", "published_at": "2026-05-23T18:10:17", "published_display": "23 May 2026 18:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Andean Precious Metals (TSX:APM) Valuation After Record Q1 Results And Planned NYSE Listing", "summary": "", "url": "https://news.google.com/rss/articles/CBMigwFBVV95cUxNeUNDcFhhWXlkamEzZXNlRm9GM2tYV3dIN3N0alllazdIMWI3M1FTRmdnZGl5V09CWDNOekpKUF9ST0JFVTlGZTh3czRtYzExWUJFdHVpV054TjBWSjJaQjlJa1ByT2VpWVAzRUx4cUhGcXQ2dmxqaVFyTHF0TTRWaURmUQ?oc=5", "source_name": "Market source", "published_at": "2026-05-13T07:00:00+00:00", "published_display": "13 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "If You Invested $1,000 in Aptorum Group Ltd (APM)", "summary": "This article analyzes the historical performance of a $1,000 investment in Aptorum Group Ltd (APM) over various periods, showing significant losses over 5 and 10 years, but a gain in the last year. It also provides a detailed overview of Aptorum Group, a clinical-stage biopharmac", "url": "https://www.stocktitan.net/tools/stock-return-calculator/APM", "source_name": "Stock Titan", "published_at": "2026-03-23T03:40:13", "published_display": "23 Mar 2026 03:40", "sentiment": "negative", "sentiment_pct": 19, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "[6-K] Aptorum Group Ltd Current Report (Foreign Issuer) | APM SEC Filing - Form 6-K", "summary": "Aptorum Group Limited filed a Form 6-K reporting the results of its 2025 annual meeting of shareholders held on March 10, 2026. The report details the voting outcomes for the re-election of Class I directors, Justin Wu and Douglas Arner, and the re-appointment of Marcum Asia CPAs", "url": "https://www.stocktitan.net/sec-filings/APM/6-k-aptorum-group-ltd-current-report-foreign-issuer-9f1e0ebee461.html", "source_name": "Stock Titan", "published_at": "2026-03-16T06:09:02", "published_display": "16 Mar 2026 06:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Blood test study takes aim at glioblastoma, deadliest brain cancer", "summary": "Aptorum Group and DiamiR Biosciences announced the publication of a study in \"Diagnostics\" demonstrating the feasibility of using microRNA-based blood tests to detect glioblastoma, the most aggressive and lethal form of brain cancer. This study, conducted with the University of P", "url": "https://www.stocktitan.net/news/APM/aptorum-group-and-diami-r-biosciences-announce-publication-of-micro-k3gy5kwhzw73.html", "source_name": "Stock Titan", "published_at": "2026-03-10T15:39:41", "published_display": "10 Mar 2026 15:39", "sentiment": "positive", "sentiment_pct": 60, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group and DiamiR Biosciences Announce Publication of microRNA Glioblastoma Biomarker Study in Diagnostics in Collaboration with the University of Pennsylvania", "summary": "Aptorum Group and DiamiR Biosciences have announced the publication of a study in Diagnostics detailing the development of microRNA-based glioblastoma biomarkers. This research, conducted with the University of Pennsylvania, outlines a minimally invasive blood plasma test for det", "url": "https://www.chartmill.com/news/APM/gnwcq-2026-3-10-aptorum-group-and-diamir-biosciences-announce-publication-of-microrna-glioblastoma-biomarker-study-in-diagnostics-in-collaboration-with-the-university-of-pennsylvania", "source_name": "ChartMill", "published_at": "2026-03-09T09:40:10", "published_display": "09 Mar 2026 09:40", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Biotech Aptorum faces Nasdaq $1 warning but keeps listing for now", "summary": "Aptorum Group (NASDAQ: APM) received a Nasdaq notification for non-compliance with the $1 minimum bid price rule. The company has a 180-calendar-day grace period until September 1, 2026, to regain compliance and is exploring options, including a potential reverse stock split. The", "url": "https://www.stocktitan.net/news/APM/aptorum-group-limited-announces-receipt-of-nasdaq-notification-a0kht9lxwp6f.html", "source_name": "Stock Titan", "published_at": "2026-03-07T14:34:44", "published_display": "07 Mar 2026 14:34", "sentiment": "negative", "sentiment_pct": 39, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "APM - Aptorum Group Ltd Latest Stock News & Market Updates", "summary": "This article provides an overview of Aptorum Group Ltd (APM) stock, highlighting its focus on developing therapeutic assets for oncology and infectious diseases, and its proposed merger with DiamiR Biosciences Corp. It also details recent corporate news, including clinical trial ", "url": "https://www.stocktitan.net/news/APM/page-8.html", "source_name": "Stock Titan", "published_at": "2026-02-26T16:51:36", "published_display": "26 Feb 2026 16:51", "sentiment": "positive", "sentiment_pct": 65, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Automated Alzheimer\u2019s risk gene test to be vetted in DiamiR lab", "summary": "Aptorum Group announced a collaboration between its subsidiary DiamiR Biosciences and Instant NanoBiosensors (INB) to validate INB's automated APOE testing platform for Alzheimer\u2019s disease risk assessment. This validation will occur in DiamiR's CLIA-certified and CAP-accredited l", "url": "https://www.stocktitan.net/news/APM/aptorum-group-announces-a-collaboration-between-diami-r-biosciences-r3knj3olkw1k.html", "source_name": "Stock Titan", "published_at": "2026-02-02T12:57:49", "published_display": "02 Feb 2026 12:57", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Announces a Collaboration Between DiamiR Biosciences and Instant NanoBiosensors (INB) to Validate INB\u2019s Automated APOE Testing Platform for Alzheimer\u2019s Disease", "summary": "Aptorum Group announced a collaboration between DiamiR Biosciences and Instant NanoBiosensors (INB) to validate INB's automated APOE testing platform for Alzheimer's disease. DiamiR will compare INB's G8 Genotyping Analyzer with its New York State approved APOE test to assess its", "url": "https://finance.yahoo.com/news/aptorum-group-announces-collaboration-between-130000993.html", "source_name": "Market source", "published_at": "2026-02-02T01:09:49", "published_display": "02 Feb 2026 01:09", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group, DiamiR announce New York state approval for APOE Genotyping test", "summary": "DiamiR Biosciences and Aptorum Group announced that DiamiR received a Clinical Laboratory Evaluation Program (CLEP) Test Approval for its APOE Genotyping test from the New York State Department of Health (NYSDOH). This approval allows DiamiR to offer its validated APOE Genotyping", "url": "https://www.tipranks.com/news/the-fly/aptorum-group-diamir-announce-new-york-state-approval-for-apoe-genotyping-test-thefly", "source_name": "TipRanks", "published_at": "2025-11-02T11:40:18", "published_display": "02 Nov 2025 11:40", "sentiment": "positive", "sentiment_pct": 71, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "symbol__ Stock Quote Price and Forecast", "summary": "This article provides a detailed stock quote and forecast for Aptorum Group Limited Class A (APM). It covers current and after-hours trading prices, key stock statistics, company information, financial data, and analyst ratings, including a 1-year stock price forecast. The report", "url": "https://www.cnn.com/markets/stocks/APM", "source_name": "CNN", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Up to $6M: Aptorum Group to Sell 1,000,000 Shares in Registered Direct Offering", "summary": "Aptorum Group (NASDAQ: APM) announced a registered direct offering of 1,000,000 Class A ordinary shares at $2.00 per share, aiming to raise $2.0 million. Concurrently, the company will issue unregistered warrants to purchase up to 2,000,000 additional shares at the same price, po", "url": "https://www.stocktitan.net/news/APM/aptorum-group-limited-announces-up-to-6-million-registered-direct-woxzu0wauuyn.html", "source_name": "Stock Titan", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group stock falls after $2 million direct offering By Investing.com", "summary": "Aptorum Group Limited's stock tumbled 23% following the announcement of a $2 million registered direct offering and concurrent private placement. The biopharmaceutical company will sell 1,000,000 Class A ordinary shares at $2.00 per share and issue warrants to purchase up to 2,00", "url": "https://au.investing.com/news/stock-market-news/aptorum-group-stock-falls-after-2-million-direct-offering-93CH-4055939", "source_name": "Investing.com Australia", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "YOOV Group Holding Limited cancelled the acquisition of Aptorum Group Limited from Jurchen Investment Corporation and others in a reverse merger transaction.", "summary": "YOOV Group Holding Limited has cancelled its acquisition of Aptorum Group Limited in a reverse merger transaction that was initially announced on March 1, 2024. The deal, valued at $250 million, would have resulted in YOOV shareholders owning approximately 90% of the combined com", "url": "https://www.marketscreener.com/quote/stock/APTORUM-GROUP-LIMITED-49518117/news/YOOV-Group-Holding-Limited-cancelled-the-acquisition-of-Aptorum-Group-Limited-from-Jurchen-Investmen-48178350/", "source_name": "MarketScreener", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 96, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Announces Completion of $3 Million Convertible Note due 2023", "summary": "Aptorum Group Limited announced the completion of a private offering of a $3 million convertible note due in December 2023. The note was solely subscribed by Aenco Technologies Limited, an entity indirectly owned by Aptorum's Non-Executive Director and major shareholder, Mr. Ian ", "url": "https://www.businesswire.com/news/home/20221216005085/en/Aptorum-Group-Announces-Completion-of-%243-Million-Convertible-Note-due-2023", "source_name": "Business Wire", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group To Acquire U Group", "summary": "Aptorum Group Limited announced its intention to acquire URF Holding Group Limited, a company focused on urban revitalization in China, through a non-binding Letter of Intent and Term Sheet. The acquisition, which involves a reverse takeover, will result in Aptorum distributing i", "url": "https://www.citybiz.co/article/396543/aptorum-group-to-acquire-u-group/", "source_name": "citybiz", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Regains Compliance with Nasdaq's Minimum Bid Price Requirement | APM Stock News", "summary": "Aptorum Group (APM) has regained compliance with Nasdaq's minimum bid price requirement by maintaining a closing bid price of at least $1.00 for ten consecutive business days between July 16 and July 30, 2025. This resolution addresses an earlier notice from Nasdaq dated April 15", "url": "https://www.quiverquant.com/news/Aptorum+Group+Regains+Compliance+with+Nasdaq's+Minimum+Bid+Price+Requirement", "source_name": "Quiver Quantitative", "published_at": "2025-10-26T05:02:20", "published_display": "26 Oct 2025 05:02", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group raises $2 million in registered direct offering", "summary": "Aptorum Group Limited has successfully raised $2 million through a registered direct offering of 1 million Class A ordinary shares priced at $2.00 per share, with a concurrent private placement potentially generating an additional $4 million from warrants. The biopharmaceutical c", "url": "https://in.investing.com/news/company-news/aptorum-group-raises-2-million-in-registered-direct-offering-93CH-5039528", "source_name": "Investing.com India", "published_at": "2025-10-10T19:32:00", "published_display": "10 Oct 2025 19:32", "sentiment": "positive", "sentiment_pct": 67, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Limited Announces Up To $6 Million Registered Direct Offering", "summary": "Aptorum Group Limited has announced a registered direct offering of 1,000,000 Class A ordinary shares at $2.00 per share, aiming to raise $2 million upfront. The offering also includes unregistered warrants to purchase up to an additional 2,000,000 shares, potentially generating ", "url": "https://markets.financialcontent.com/startribune/article/gnwcq-2025-10-10-aptorum-group-limited-announces-up-to-6-million-registered-direct-offering", "source_name": "FinancialContent", "published_at": "2025-10-10T09:54:00", "published_display": "10 Oct 2025 09:54", "sentiment": "positive", "sentiment_pct": 59, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "APM | Aptorum Group Limited Class Institutional Ownership", "summary": "This article provides an overview of Aptorum Group Limited (APM) Class A Ordinary Shares, focusing on institutional ownership, insider trading, and various financial metrics. It includes data sections for Congress trading, whale activity, corporate lobbying, revenue breakdown, an", "url": "https://www.quiverquant.com/stock/APM/institutions/", "source_name": "Quiver Quantitative", "published_at": "2025-09-01T12:51:25", "published_display": "01 Sep 2025 12:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group\u2019s Latest Surge: An Opportunity?", "summary": "Aptorum Group Limited (APM) saw a significant stock surge of 134.65% following positive trial results, FDA designation announcements, and an impending all-stock merger with DiamiR Biosciences. The company also maintained NASDAQ compliance, positioning itself for potential growth ", "url": "https://stockstotrade.com/news/aptorum-group-limited-apm-news-2025_08_21/", "source_name": "StocksToTrade", "published_at": "2025-08-21T10:04:00", "published_display": "21 Aug 2025 10:04", "sentiment": "positive", "sentiment_pct": 72, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Limited Regains Compliance with NASDAQ's Minimum Bid Price Requirement", "summary": "Aptorum Group Limited has regained compliance with Nasdaq's minimum bid price requirement, fulfilling the condition of its Class A ordinary shares closing at $1.00 or higher for 10 consecutive business days. This comes after an initial notice from Nasdaq in April 2025. The compan", "url": "https://markets.financialcontent.com/worldnow.kwtv/article/gnwcq-2025-8-4-aptorum-group-limited-regains-compliance-with-nasdaqs-minimum-bid-price-requirement", "source_name": "FinancialContent", "published_at": "2025-08-04T08:15:00", "published_display": "04 Aug 2025 08:15", "sentiment": "positive", "sentiment_pct": 70, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "APM Stock Price, News & Analysis", "summary": "Aptorum Group Limited (NASDAQ: APM) is a clinical-stage biopharmaceutical company focused on oncology and infectious diseases, also involved in diagnostics and healthcare services. APM is currently undergoing an all-stock merger with DiamiR Biosciences Corp., which will make Diam", "url": "https://www.stocktitan.net/overview/APM/", "source_name": "Stock Titan", "published_at": "2025-04-24T19:39:14", "published_display": "24 Apr 2025 19:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group (APM) Stock Price, News & Analysis", "summary": "", "url": "https://news.google.com/rss/articles/CBMiUkFVX3lxTE9SRzVLZEc3WTdGYVBwYjB4X1hyYkFlbFpYWHZ4MFdoWWstZFhNWXBISklfc0k3VnROLURuQmZSQjRqeFNnYmJjMklNQlVTSTNUOWc?oc=5", "source_name": "Stock Titan", "published_at": "2025-04-24T17:29:35+00:00", "published_display": "24 Apr 2025 17:29", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Limited Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency", "summary": "Aptorum Group Limited announced it received a Nasdaq notification for not meeting the minimum bid price requirement of $1 per share. The company has a 180-calendar-day grace period until October 14, 2025, to regain compliance and is exploring options including a reverse stock spl", "url": "https://www.dcnewsnow.com/business/press-releases/globenewswire/9423537/aptorum-group-limited-announces-receipt-of-nasdaq-notification-regarding-minimum-bid-price-deficiency/", "source_name": "DC News Now", "published_at": "2025-04-16T12:27:00", "published_display": "16 Apr 2025 12:27", "sentiment": "negative", "sentiment_pct": 29, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Aptorum Group Limited Announces Pricing of $3.0 Million Registered Direct Offering", "summary": "Aptorum Group Limited (NASDAQ: APM) announced it has entered into a securities purchase agreement with several institutional investors for a registered direct offering of 1,535,000 Class A Ordinary Shares at $2.00 per share, aiming to raise approximately $3.0 million. The offerin", "url": "https://markets.financialcontent.com/worldnow.kwtv/article/gnwcq-2025-1-2-aptorum-group-limited-announces-pricing-of-30-million-registered-direct-offering", "source_name": "FinancialContent", "published_at": "2025-01-02T10:55:00", "published_display": "02 Jan 2025 10:55", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T12:30:39+00:00", "published_display": "13 Jul 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 93, "total_relevant": 45, "sentiment_summary": {"positive": 12, "negative": 7, "neutral": 26, "score": 52, "total": 45, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 77, "events": [{"event": "general", "label": "Market update", "weight": 11.55, "count": 21}, {"event": "earnings", "label": "Earnings", "weight": 5.5, "count": 12}, {"event": "deals", "label": "Deals and strategy", "weight": 4.4, "count": 8}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 1.1, "count": 2}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}], "positive_events": 12, "negative_events": 7}, "market_context": {"has_market_context": true, "latest_close": 0.78, "latest_week": "2026-07-10", "one_week_move": -2.5, "four_week_move": -8.8, "twelve_week_move": -11.7, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.141819, "market_dynamics_buy_signal": false, "relative_strength": -45.744885, "fair_value_gap": -61.0, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 37.6679, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.5% over one week, -8.8% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 59, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 9}, {"label": "Market source", "count": 7}, {"label": "GlobeNewswire", "count": 3}, {"label": "Quiver Quantitative", "count": 3}, {"label": "FinancialContent", "count": 3}, {"label": "Donan\u0131mHaber", "count": 2}, {"label": "MT Newswires", "count": 2}, {"label": "simplywall.st", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 37}, {"label": "Industry context", "count": 8}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 21}, {"label": "Earnings", "count": 12}, {"label": "Deals and strategy", "count": 8}, {"label": "Regulatory and legal", "count": 2}, {"label": "Analyst action", "count": 1}, {"label": "Guidance", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "52/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "77/100 classification confidence."}, {"label": "Company focus", "value": "37", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.5% over one week, -8.8% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Negative", "tone": "negative", "text": "Aptorum Group Limited (APM) Edges Lower Amid Narrow Trading Range - Rating Change"}], "updated_at": "2026-07-16T11:43:06.905676+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}